The academy conducted the survey with Gilead Sciences HIV Medical Affairs, polling 409 PrEP users and 188 prescribers between April 21 and May 15.
Four survey findings:
1. Of respondents who stopped taking PrEP, 85 percent said they were not engaged in behaviors that put them at risk for HIV.
2. Only 11 respondents said an outside factor — such as losing insurance coverage — prevented them from getting the medication.
3. Eighty-nine percent of providers did not recommend patients change their PrEP routines during shelter-in-place.
4. Forty-seven percent of providers said some of their patients elected to stop using PrEP during shelter-in-place.
The academy presented survey data June 8 at the virtual International AIDS Conference and shared its findings with Becker’s via email.
More articles on infection control:
Advocate Aurora leaders told oncology staff not to wear masks in March, nurse says
American College of Physicians: Best practice tips when using masks to prevent COVID-19
More than 5,000 hospital-acquired COVID-19 cases reported since mid-May, CDC says
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
